Description

Dapagliflozin Propanediol Monohydrate API is a highly effective active pharmaceutical ingredient used for the management of Type 2 diabetes mellitus. It belongs to the SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors class, which lowers blood glucose levels by preventing glucose reabsorption in the kidneys, allowing excess glucose to be excreted through urine. This API is commonly formulated into oral tablets either as monotherapy or in combination with other antidiabetic agents to improve blood sugar control in diabetic patients.